• Return to Headlines

Watch for Continued Gains in Shares of Pfizer Inc (PFE)

By David Diaz

Pfizer Inc (NYSE:PFE) traded at a new 52-week high today of $44.43. This new high was reached on below average trading volume as 2.4 million shares traded hands, while the average 30-day volume is approximately 18.1 million shares.

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets healthcare products worldwide. The Company's products include medicines, vaccines, medical devices, and consumer healthcare products.

In the past 52 weeks, shares of Pfizer Inc have traded between a low of $33.20 and a high of $44.43 and are now at $44.38, which is 34% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.6% while the 200-day MA has risen 0.5%.

Pfizer Inc (NYSE:PFE) defies analysts with a current price ($44.38) 10.5% above its average consensus price target of $39.71. The stock should find initial support at its 50-day moving average (MA) of $40.82 and further support at its 200-day MA of $37.35.

SmarTrend recommended that subscribers consider buying shares of Pfizer Inc on July 12th, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $37.39. Since that recommendation, shares of Pfizer Inc have risen 17.9%. We continue to monitor PFE for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows pfizer inc

Ticker(s): PFE